Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1991 Oct;104(2):490–494. doi: 10.1111/j.1476-5381.1991.tb12456.x

Inhibition of the myocardial Ca(2+)-current (ICa) by the enantiomers of DPI 201-106 and BDF 8784.

U Ravens 1, T Pfeifer 1, E Wettwer 1, M Grundke 1
PMCID: PMC1908581  PMID: 1665740

Abstract

1. We studied the stereoselectivity of the effects of the enantiomers of the cardiotonic agent DPI 201-106 (4-[3'-(4"-benzhydryl-1"-piperazinyl)-2'-hydroxypropoxy]-1H-indole-2- carbonitrile, DPI) and its methyl-for-carbonitrile analogue BDF 8784 on cardiac calcium currents (ICa) of guinea-pig ventricular myocytes. The actions of the S- and R-enantiomers were compared with those of the racemate. 2. Racemic, S- and R-DPI depressed ICa in a concentration-dependent manner, the IC50 values were 1.1 mumol l-1 for racemic and S-DPI, and 1.2 mumol l-1 for R-DPI, respectively. Racemic, S- and R-BDF 8784 also reduced ICa, the respective IC50 values were 3.6 mumol l-1 for racemic BDF 8784, 1.3 mumol l-1 for S-BDF 8784 and 1.1 mumol l-1 for R-BDF 8784. 3. Neither the DPI nor the BDF 8784 enantiomers alter the time course of inactivation of ICa. The steady-state inactivation curve for ICa was shifted along the voltage axis to negative membrane potentials. The block of ICa was dependent on the membrane potential and increased with membrane depolarization. 4. Our findings indicate that DPI and BDF 8784 inhibit ICa in a non-stereoselective manner, which contrasts the opposite effects of the DPI enantiomers on Na+ channels.

Full text

PDF
490

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Armah B. I., Pfeifer T., Ravens U. Reversal of the cardiotonic and action-potential prolonging effects of DPI 201-106 by BDF 8784, a methyl-indol derivative. Br J Pharmacol. 1989 Apr;96(4):807–816. doi: 10.1111/j.1476-5381.1989.tb11888.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bean B. P. Nitrendipine block of cardiac calcium channels: high-affinity binding to the inactivated state. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6388–6392. doi: 10.1073/pnas.81.20.6388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Borchard M., Ravens U. Intracellularly applied sodium mimics the effects of ouabain in single cardiac myocytes. Eur J Pharmacol. 1986 Nov 19;131(2-3):269–272. doi: 10.1016/0014-2999(86)90581-9. [DOI] [PubMed] [Google Scholar]
  4. Buggisch D., Isenberg G., Ravens U., Scholtysik G. The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparations. Eur J Pharmacol. 1985 Dec 3;118(3):303–311. doi: 10.1016/0014-2999(85)90141-4. [DOI] [PubMed] [Google Scholar]
  5. Hamill O. P., Marty A., Neher E., Sakmann B., Sigworth F. J. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch. 1981 Aug;391(2):85–100. doi: 10.1007/BF00656997. [DOI] [PubMed] [Google Scholar]
  6. Hamilton S. L., Yatani A., Brush K., Schwartz A., Brown A. M. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes. Mol Pharmacol. 1987 Mar;31(3):221–231. [PubMed] [Google Scholar]
  7. Holck M., Osterrieder W. Interaction of the cardiotonic agent DPI 201-106 with cardiac Ca2+ channels. J Cardiovasc Pharmacol. 1988 Apr;11(4):478–482. doi: 10.1097/00005344-198804000-00015. [DOI] [PubMed] [Google Scholar]
  8. Hosey M. M., Lazdunski M. Calcium channels: molecular pharmacology, structure and regulation. J Membr Biol. 1988 Sep;104(2):81–105. doi: 10.1007/BF01870922. [DOI] [PubMed] [Google Scholar]
  9. Isenberg G. Cardiac Purkinje fibers: cesium as a tool to block inward rectifying potassium currents. Pflugers Arch. 1976 Sep 30;365(2-3):99–106. doi: 10.1007/BF01067006. [DOI] [PubMed] [Google Scholar]
  10. Kohlhardt M., Fröbe U., Herzig J. W. Modification of single cardiac Na+ channels by DPI 201-106. J Membr Biol. 1986;89(2):163–172. doi: 10.1007/BF01869712. [DOI] [PubMed] [Google Scholar]
  11. Romey G., Lazdunski M. Lipid-soluble toxins thought to be specific for Na+ channels block Ca2+ channels in neuronal cells. Nature. 1982 May 6;297(5861):79–78. doi: 10.1038/297079a0. [DOI] [PubMed] [Google Scholar]
  12. Romey G., Quast U., Pauron D., Frelin C., Renaud J. F., Lazdunski M. Na+ channels as sites of action of the cardioactive agent DPI 201-106 with agonist and antagonist enantiomers. Proc Natl Acad Sci U S A. 1987 Feb;84(3):896–900. doi: 10.1073/pnas.84.3.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Scholtysik G., Quast U., Schaad A. Evidence for different receptor sites for the novel cardiotonic S-DPI 201-106, ATX II and veratridine on the cardiac sodium channel. Eur J Pharmacol. 1986 Jun 5;125(1):111–118. doi: 10.1016/0014-2999(86)90089-0. [DOI] [PubMed] [Google Scholar]
  14. Scholtysik G., Salzmann R., Berthold R., Herzig J. W., Quast U., Markstein R. DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn Schmiedebergs Arch Pharmacol. 1985 May;329(3):316–325. doi: 10.1007/BF00501887. [DOI] [PubMed] [Google Scholar]
  15. Siegl P. K., Garcia M. L., King V. F., Scott A. L., Morgan G., Kaczorowski G. J. Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels. Naunyn Schmiedebergs Arch Pharmacol. 1988 Dec;338(6):684–691. doi: 10.1007/BF00165635. [DOI] [PubMed] [Google Scholar]
  16. Thormann J., Kramer W., Kindler M., Kremer F. P., Schlepper M. Comparative efficacy of the new cardiotonic agent DPI 201-106 versus dobutamine in dilated cardiomyopathy: analysis by serial pressure/volume relations and "on-line" MVO2 assessment. J Cardiovasc Pharmacol. 1986 Jul-Aug;8(4):749–757. [PubMed] [Google Scholar]
  17. Wang G., Dugas M., Ben Armah I., Honerjäger P. Interaction between DPI 201-106 enantiomers at the cardiac sodium channel. Mol Pharmacol. 1990 Jan;37(1):17–24. [PubMed] [Google Scholar]
  18. Yatani A., Brown A. M., Schwartz A. Bepridil block of cardiac calcium and sodium channels. J Pharmacol Exp Ther. 1986 Apr;237(1):9–17. [PubMed] [Google Scholar]
  19. Yatani A., Kunze D. L., Brown A. M. Effects of dihydropyridine calcium channel modulators on cardiac sodium channels. Am J Physiol. 1988 Jan;254(1 Pt 2):H140–H147. doi: 10.1152/ajpheart.1988.254.1.H140. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES